Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Cancer Genomics & Proteomics
    • Anticancer Research
    • In Vivo

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Cancer Genomics & Proteomics
  • Other Publications
    • Cancer Genomics & Proteomics
    • Anticancer Research
    • In Vivo
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Cancer Genomics & Proteomics

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
  • About Us
    • General Policy
    • Contact
  • Visit iiar on Facebook
  • Follow us on Linkedin

The Cancer Genome Atlas

  • Open Access
    Effects of Isthmus Topography on the Molecular Characteristics of BRAF-mutant Papillary Thyroid Cancer
    CHI-YU KUO, SHEENA YI-HSIN CHENG, YI-CHIUNG HSU and SHIH-PING CHENG
    Cancer Genomics & Proteomics May 2026, 23 (3) 470-482; DOI: https://doi.org/10.21873/cgp.20585
  • Open Access
    POLD1 Is Required for Cell Cycle Progression by Overcoming DNA Damage in Malignant Pleural Mesothelioma
    DAIKI SHIMIZU, MIKU ISHIBASHI, TADAAKI YAMADA, YUKI TODA, SHIGEKUNI HOSOGI and EISHI ASHIHARA
    Cancer Genomics & Proteomics March 2024, 21 (2) 158-165; DOI: https://doi.org/10.21873/cgp.20437
  • Open Access
    Loss of F-Box and Leucine Rich Repeat Protein 5 (FBXL5) Expression Is Associated With Poor Survival in Patients With Hepatocellular Carcinoma After Curative Resection: A Two-institute Study
    YOON AH CHO, SUNG-EUN KIM, CHEOL KEUN PARK, HYUN HEE KOH, CHEOL-KEUN PARK and SANG YUN HA
    Cancer Genomics & Proteomics May 2023, 20 (3) 298-307; DOI: https://doi.org/10.21873/cgp.20382
  • Open Access
    Co-occurrent Alterations of Alzheimer's Genes and Prostate Cancer Genes in Prostate Cancer
    STEVEN LEHRER and PETER H. RHEINSTEIN
    Cancer Genomics & Proteomics May 2020, 17 (3) 271-275; DOI: https://doi.org/10.21873/cgp.20187
  • Open Access
    Increased RNA Expression of von Willebrand Factor Gene Is Associated With Infiltrating Lobular Breast Cancer and Normal PAM50 Subtype
    STEVEN LEHRER, SHERYL GREEN, FRANCINE R. DEMBITZER, PETER H. RHEINSTEIN and KENNETH E. ROSENZWEIG
    Cancer Genomics & Proteomics May 2019, 16 (3) 147-153; DOI: https://doi.org/10.21873/cgp.20120
  • Open Access
    Three Poliovirus Sequences in the Human Genome Associated With Colorectal Cancer
    STEVEN LEHRER and PETER H. RHEINSTEIN
    Cancer Genomics & Proteomics January 2019, 16 (1) 65-70; DOI: https://doi.org/10.21873/cgp.20112
  • Open Access
    Copy Number Alterations in Tumor Genomes Deleting Antineoplastic Drug Targets Partially Compensated by Complementary Amplifications
    HA VU TRAN, ALEXANDRA K. KIEMER and VOLKHARD HELMS
    Cancer Genomics & Proteomics September 2018, 15 (5) 365-378; DOI: https://doi.org/10.21873/cgp.20095
  • Open Access
    Expression of the Vesicular Monoamine Transporter Gene Solute Carrier Family 18 Member 1 (SLC18A1) in Lung Cancer
    STEVEN LEHRER and PETER H. RHEINSTEIN
    Cancer Genomics & Proteomics September 2018, 15 (5) 387-393; DOI: https://doi.org/10.21873/cgp.20097
Cancer & Genome Proteomics

© 2026 Cancer Genomics & Proteomics

Powered by HighWire